Skip to content
AnalystLens
Back to EXELIncome Statement

Exelixis EPS (Diluted) 2009-2027 | EXEL

Annual FY2009–FY2026 · quarterly through Q3 FY2027

Latest annual · FY2026

$2.78

+58.0%YoY vs FY2025Source: 10-KFY2026

From −$1.26 in FY2009 to $2.78 in FY2026.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY27$0.79+43.6%$0.82+26.2%$0.85+23.2%Not reported
FY26$0.55+358.3%$0.65−15.6%$0.69+72.5%Not reported
FY25$0.12$0.77$0.40Not reported
FY23$0.12−42.9%$0.25+13.6%$0.00−100.0%Not reported
FY22$0.21$0.22−26.7%$0.23+91.7%Not reported
Share20%19%24%37%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionGrowing
CAGR

+22.2%

FY2020
$1.02
FY2026
$2.78

5 years selected · on the chart

EPS (Diluted) History

Year-over-year comparison from 10-K annual reports

  1. $2.78
YoY changeLargest recent move+351.0%in FY18Latest +58.0%

5 older moves run past ±150% (largest +351.0%); point at, tap or drag across the bars to read one.

EPS (Diluted), period by period

PeriodValueChangeSource
FY2026$2.78+58.0%10-K
FY2025$1.76+170.8%10-K
FY2023$0.65+16.1%10-K
FY2022$0.56−22.2%10-K
FY2021$0.72−29.4%10-K
FY2020$1.02−53.8%10-K
FY2018$2.21+351.0%10-K
FY2017$0.49+275.0%10-K
FY2016−$0.28+78.9%10-K
FY2013−$1.33−44.6%10-K
FY2012−$0.92−258.6%10-K
FY2011$0.58+168.2%10-K
FY2010−$0.85+32.5%10-K
FY2009−$1.26—10-K

What is eps (diluted)?

Diluted earnings per share (EPS) can be defined as net income divided by the total number of shares outstanding including all dilutive securities such as stock options, warrants, and convertible bonds.

What is Exelixis's current eps (diluted)?

Exelixis (EXEL) annual eps (diluted) for 2026 was $2.78, a 57.95% increase from 2025. Exelixis eps (diluted) for the quarter ending October 2, 2026 was $0.85.

What was Exelixis's eps (diluted) in 2025?

Exelixis annual eps (diluted) for 2025 was $1.76, a 170.77% increase from 2023.

What was Exelixis's eps (diluted) in 2023?

Exelixis annual eps (diluted) for 2023 was $0.65, a 16.07% increase from 2022.

What is Exelixis's 5-year eps (diluted) CAGR?

Exelixis eps (diluted) grew at a compound annual growth rate (CAGR) of 31.02% from FY2021 to FY2026, going from $0.72 to $2.78 over 5 years.

Company
Exelixis
Ticker
EXEL
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)